Sonmol
PrivateLast Round
Strategic
Jul 18, 2024
Est. Valuation
$367.08M
Total Funding Raised
$148.22M
Company Overview
Sonmol operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Strategic round in July 2024.
Sonmol is a digital health company that develops AI-powered respiratory disease management platforms and connected medical devices for the diagnosis and treatment of conditions such as asthma and COPD.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonmol Comparables
Compare Sonmol with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResMed Inc | 83% | |
| Cohero Health, Inc. | 78% | |
| Adherium Limited | 77% |
For institutional investors. Book with your work email.
Sonmol Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 18, 2024 | ||||
| Series E Extension | Aug 19, 2022 | ||||
| Series E | Nov 1, 2021 | ||||
| Series D | Dec 22, 2020 | ||||
| Series C | Aug 1, 2019 | ||||
Series B Extension | Oct 22, 2018 |
For institutional investors. Book with your work email.
Sonmol Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series E |
| 健壹资本 | Series C |
| Shanghai Shengyu Equity Investment Fund Management | Series E |
| Sunshine Insurance Group | Series D |
| CICC ALPHA | Series D |
| Changchun City Equity Investment Fund Management Co., Ltd. | Strategic |
| Xiang He Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2024
$8.3M raised from Changchun City Equity Investment Fund Management Co., Ltd.
- Aug 19, 2022
Completed a Series E Extension round of funding.
For institutional investors. Book with your work email.
Sonmol Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sonmol's valuation, stock price, and market status.
Is Sonmol a public or private company?
Sonmol is a private company.
What is the current stock price of Sonmol?
Sonmol is a private company, so its shares have no public market price. Caplight tracks Sonmol's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sonmol worth (valuation)?
Sonmol's valuation is estimated at $367.1M based on funding round data.
Can I buy Sonmol stock?
Sonmol shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sonmol's last funding round?
Sonmol's most recent funding round was Strategic on July 18, 2024.
Who are the main investors in Sonmol?
Key investors in Sonmol include IDG Capital, CICC ALPHA, Xiang He Capital.
Will Sonmol IPO soon?
No public IPO plans have been announced for Sonmol.
How can I track Sonmol secondary market activity?
Caplight tracks bids, offers, and trades in Sonmol's shares on secondary markets.